VANGUARD GROUP INC, a registered investment adviser, initiated a new position in Centene Corporation (NYSE:CNC) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 52,236,890 shares of the Healthcare company, valued at approximately $2.1B as of the filing date.
Centene Corporation's stock currently trades at $43.58 with a market capitalization of $19.9B.
